Dvorit Samid
Executive Vice President of Medical AffairsDr. Dvorit Samid, Ph.D. serves as Executive Vice President of Medical Affairs at Aardvark Therapeutics Inc. since August 2021 and was Head of Medical Affairs at Aardvark Therapeutics, Inc until August 2021. Dr. Samid joined Aardvark in 2020. She served as Senior Vice President of Medical Affairs at NantKwest, Inc. since September 2015 until April 18, 2017. Dr. Samid has many years of oncology research and drug development experience. She served as Vice President of Medical Affairs at Synta Pharmaceuticals Corp. from March 12, 2012 to September 4, 2015. Dr. Samid served as a Vice President, Medical Affairs of Imclone Systems Inc. from August 1, 2005 to 2009. Dr. Samid served as Executive Director of Medical Affairs of ABRAXIS Oncology, American Pharmaceutical Partners Inc.'s proprietary pharmaceutical division, since December 15, 2003. She served as head of Roche Pharmaceuticals' U.S. Oncology Medical Team, where she was responsible for developing a wide range of products, including new indications for marketed products. Prior to Roche, she headed a research section at the National Cancer Institute (NCI), where she coordinated preclinical and clinical studies of novel anti-cancer drugs. She serves as a Director of Abraxis Oncology, Inc. She served as a tenured faculty member of the Department of Medicine at the University of Virginia. She served also as Associate Professor at the University of Virginia’s Medical School and as Section Chief at the National Cancer Institute. She has authored more than 80 publications in oncology and holds 19 patents. She earned a bachelor degree in biology from the Hebrew University in Jerusalem Israel and a doctorate degree in biological sciences from the Catholic University of America, Washington DC.
Positions
- Company NameAardvark Therapeutics, Inc.Stock CodeAARDPositionExecutive Vice President of Medical AffairsColleagues
